Eur Respir J 2000; 15: 248-253
Copyright © ERS Journals Ltd 2000
Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre
M Ichinose,
T Takahashi,
H Sugiura,
N Endoh,
M Miura,
Y Mashito,
and
K Shirato
Airway hyperresponsiveness (AHR), in which airway inflammation has been reported to be a key factor, is an important component of asthma. However the precise role of inflammation in AHR is still unclear. In this report, airway inflammatory changes were assessed using hypertonic saline-induced sputum examination and exhaled nitric oxide analysis, and the relation between AHR to methacholine, airway calibre forced expiratory volume in one second (FEV1) and airway inflammatory indices examined. Furthermore, the changes in these variables were also examined by means of 8 weeks' open uncontrolled inhaled steroid administration (800 microg x beclomethasone x day(-1)). Asthmatic subjects had higher eosinophil counts and bradykinin concentration in induced sputum and higher exhaled NO levels, and showed AHR to methacholine. Baseline AHR significantly correlated with FEV1 but not with indices of inflammation in sputum or exhaled air. Steroid inhalation therapy was associated with a reduction in eosinophil and bradykinin concentration in sputum and NO levels in exhaled air and an improvement in FEV1 and AHR. The changes in FEV1 and AHR were significantly related to changes in markers in sputum and exhaled air (p<0.01 for each). These results suggest that baseline airway hyperresponsiveness can be predicted from the airway calibre but not from inflammatory parameters in sputum or exhaled air. In contrast, the reversible component of airway hyperresponsiveness appeared to be associated with the reduction in airway inflammation.
This article has been cited by other articles:

|
 |

|
 |
 
J. Manfreda, M. R. Sears, M. R. Becklake, M. Chan-Yeung, H. Dimich-Ward, H. C. Siersted, P. Ernst, L. Sweet, L. Van Til, D. M. Bowie, et al.
Geographic and Gender Variability in the Prevalence of Bronchial Responsiveness in Canada
Chest,
May 1, 2004;
125(5):
1657 - 1664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. DE MEER, D. HEEDERIK, and D. S. POSTMA
Bronchial Responsiveness to Adenosine 5'-Monophosphate (AMP) and Methacholine Differ in Their Relationship with Airway Allergy and Baseline FEV1
Am. J. Respir. Crit. Care Med.,
February 1, 2002;
165(3):
327 - 331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Van Den BERGE, H. A. M. KERSTJENS, R. J. MEIJER, D. M. DE REUS, G. H. KOETER, H. F. KAUFFMAN, and D. S. POSTMA
Corticosteroid-induced Improvement in the PC20 of Adenosine Monophosphate Is More Closely Associated with Reduction in Airway Inflammation than Improvement in the PC20 of Methacholine
Am. J. Respir. Crit. Care Med.,
October 1, 2001;
164(7):
1127 - 1132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. ten BRINKE, A. H. ZWINDERMAN, P. J. STERK, K. F. RABE, and E. H. BEL
Factors Associated with Persistent Airflow Limitation in Severe Asthma
Am. J. Respir. Crit. Care Med.,
September 1, 2001;
164(5):
744 - 748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mio, X. Liu, M. L. Toews, Y. Adachi, D. J. Romberger, J. R. Spurzem, and S. I. Rennard
Bradykinin augments fibroblast-mediated contraction of released collagen gels
Am J Physiol Lung Cell Mol Physiol,
July 1, 2001;
281(1):
L164 - L171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Van Den BERGE, R. J. MEIJER, H. A. M. KERSTJENS, D. M. de REUS, G. H. KOETER, H. F. KAUFFMAN, and D. S. POSTMA
PC20 Adenosine 5'-Monophosphate Is More Closely Associated with Airway Inflammation in Asthma Than PC20 Methacholine
Am. J. Respir. Crit. Care Med.,
June 1, 2001;
163(7):
1546 - 1550.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the European Respiratory Society.
|